...
首页> 外文期刊>Frontiers in Microbiology >Florfenicol As a Modulator Enhancing Antimicrobial Activity: Example Using Combination with Thiamphenicol against Pasteurella multocida
【24h】

Florfenicol As a Modulator Enhancing Antimicrobial Activity: Example Using Combination with Thiamphenicol against Pasteurella multocida

机译:氟苯尼考作为一种增强抗菌活性的调节剂:以甲硫酚联合抗多杀巴斯德氏菌为例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Synergistic effects between the same class of antibiotics are rarely reported. Our previous study found synergistic-like interaction between florfenicol (FFC) and thiamphenicol (TAP) against Staphylococcus aureus . Here, the enhanced antimicrobial activity was evaluated in 97 clinical isolates of both Gram-negative and Gram-positive bacteria. Susceptible strains were initially identified by checkerboard microdilution assay (fractional inhibitory concentration index [FICI] ≤ 0.625), followed by confirmation of synergism using the time-kill methodology (≥2 log_(10)CFU/ml reduction). In all, 43% of Pasteurella multocida tested were susceptible to the enhanced bactericidal effect. In chicken fowl cholera models, FFC and TAP combination at much lower dosage that is correspondent to their MIC deduction provided maximum protection in vivo . Furthermore, synergistic combination of FFC with oxytetracycline (OTC) against Pseudomonas aeruginosa in vitro was also demonstrated. Based on the enhanced uptake of TAP and OTC, FFC presumably elicits enhanced antimicrobial activity in an orderly manner through alteration of bacterial membrane permeability or efflux systems and subsequent increase of intracellular concentration of the antibiotics used in combination. Results of ethidium bromide accumulation assay and RNA-seq showed little evidence for the involvement of efflux pumps in the synergy but further investigation is required. This study suggests the potentiality of a novel combination regimen involving FFC as an initiating modulator effective against both Gram-positive and Gram-negative bacteria depending on the antibiotics that are combined. The observed improvement of bacteriostatic effect to bactericidal, and the extended effectiveness against FFC-resistant bacterial strains warrant further studies.
机译:很少报道同类抗生素之间的协同作用。我们先前的研究发现氟苯尼考(FFC)和甲砜霉素(TAP)对金黄色葡萄球菌有协同作用。在此,对革兰氏阴性菌和革兰氏阳性菌的97种临床分离株评估了增强的抗菌活性。最初通过棋盘微稀释测定(分数抑制浓度指数[FICI]≤0.625)识别出易感菌株,然后使用时间杀灭方法(≥2 log_(10)CFU / ml降低)确认协同作用。总共,测试的多杀巴斯德氏菌中有43%对增强的杀菌作用敏感。在鸡霍乱模型中,FFC和TAP的组合剂量低得多,与MIC降低相对应,可在体内提供最大的保护。此外,还证明了FFC与土霉素对铜绿假单胞菌的协同作用。基于TAP和OTC的吸收增加,FFC可能通过改变细菌膜的通透性或外排系统以及随后增加组合使用的抗生素的细胞内浓度而有序地增强抗菌活性。溴化乙锭积累测定和RNA-seq的结果显示,很少有证据表明外排泵参与协同作用,但需要进一步研究。这项研究表明一种新的联合疗法的潜力,其中包括将FFC作为有效对抗革兰氏阳性和革兰氏阴性细菌的起始调节剂,具体取决于所结合的抗生素。观察到的对杀菌作用的抑菌作用得到改善,以及针对耐FFC的细菌菌株的扩展效力值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号